DNMT1 and neoplasm: To further explore TEC heterogeneity as relates to Dnmt1 expression and anti-tumor immune responses, we carried out scRNA-seq on FACS-isolated CD45-/CD31+ ECs from collagenase-dispersed, normal mammary glands.